Cardiometabolic Therapeutics · Prescription Drugs
Esperion revenue, results and funding
Esperion filed revenue of $403.1M for 2025.
Data updated Nov 22, 2026 · Back to the company report
$403.1MRevenue, 2025
−$22.7MNet income, 2025
Results by year
| Year | Revenue | Net income | Total assets | LANG_CR_S_M_TAX_PAID | LANG_CR_S_M_TAX_EXPENSE | LANG_CR_S_M_BUYBACKS | LANG_CR_S_M_CAPEX | LANG_CR_S_M_SBC | LANG_CR_S_M_RND | LANG_CR_S_M_OPERATING_INCOME | LANG_CR_S_M_CASH | LANG_CR_S_M_DEBT |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025 | $403.1M | −$22.7M | $465.9M | $612k | $1.8M | – | $0 | $9.9M | $47.9M | $60.3M | $167.9M | – |
| 2024 | $332.3M | −$51.7M | $343.8M | $0 | $0 | – | $317k | $12M | $46.2M | $54.4M | $144.8M | – |
| 2023 | $116.3M | −$209.2M | $205.8M | $0 | $0 | – | $0 | $12M | $86.1M | −$155.6M | $82.2M | – |
| 2022 | $75.5M | −$233.7M | $247.9M | – | $0 | – | $0 | $15.2M | $118.9M | −$179.5M | $124.8M | – |
| 2021 | $78.4M | −$269.1M | $381.6M | – | $0 | $0 | $0 | $24.3M | $106M | −$226.7M | $208.9M | – |
| 2020 | $227.5M | −$143.6M | $353.3M | – | $0 | $55M | $869k | $28.4M | $146.9M | −$121.4M | $305M | – |
| 2019 | $148.4M | −$97.2M | $214.4M | – | $0 | $0 | $953k | $25.9M | $175.6M | −$93.1M | $166.1M | – |
| 2018 | $0 | −$201.8M | $143.5M | – | $0 | $0 | $151k | $24M | $171.5M | −$204.6M | $37M | – |
| 2017 | – | −$167M | $277.8M | – | $0 | – | $19k | $18.6M | $147.6M | −$169M | $34.5M | – |
| 2016 | – | −$75M | $245.2M | – | $0 | – | $94k | $16M | $57.9M | −$76.2M | $38.2M | $1M |
| 2015 | – | −$49.8M | $295.6M | – | $0 | – | $325k | $12.7M | $29.8M | −$50M | $77.3M | $2.7M |
| 2014 | – | −$36.4M | $143.3M | – | $0 | – | $873k | $3.7M | $25.3M | −$36.2M | $85M | $4.2M |
| 2013 | – | −$26.1M | $78.3M | – | $0 | – | $31k | $1.2M | $16M | −$22.8M | $56.5M | – |
| 2012 | – | −$11.7M | $7.3M | – | $0 | – | $7k | $80k | $8M | −$10.2M | $6.5M | $7.5M |
| 2011 | – | −$10.8M | – | – | $0 | – | $34k | $78k | $7.8M | −$10.2M | $1.6M | – |
Sources: SEC
How to cite
Esperion, Financials. Alion, Nov 22, 2026. https://alion.io/company/esperion/financials
